314 Results

People

  1. O'Reilly
    O'Reilly
  2. Jarnagin
    Jarnagin
  3. Brennan
    Brennan
  4. Klimstra
    Klimstra
  5. D'Angelica
    D'Angelica
  6. Wei
    Wei
  7. Allen
    Allen
  8. Gonen
    Gonen
  9. Basturk
    Basturk
  10. Kingham
    Kingham

Groups

  1. Center for Pancreatic Cancer Research (177)
  2. Surgery (106)
  3. Department of Medicine (92)
  4. Solid Tumor Oncology Division (82)
  5. Department of Pathology and Laboratory Medicine (78)
  6. Gastrointestinal Oncology Service (78)
  7. Sloan Kettering Institute Postdocs (72)
  8. GSK Faculty (60)
  9. Epidemiology and Biostatistics (49)
  10. Sloan Kettering Institute Faculty (48)
  1. "pancreas tumor"
Formats
  1. Journal Article (267)
  2. Review (24)
  3. Editorial (9)
  4. Correspondence (4)
  5. Guidelines (3)
  6. Miscellaneous (3)
  7. Research Letter (3)
  8. Conference Paper (1)
Groups
  1. Center for Pancreatic Cancer Research (177)
  2. Surgery (106)
  3. Department of Medicine (92)
  4. Solid Tumor Oncology Division (82)
  5. Department of Pathology and Laboratory Medicine (78)
  6. Gastrointestinal Oncology Service (78)

More Groups

People
  1. David Klimstra (59)
  2. Eileen O'Reilly (51)
  3. William Jarnagin (33)
  4. Murray Brennan (31)
  5. Michael D'Angelica (30)
  6. Alice Wei (28)

More People

Years
  1. 2025 (7)
  2. 2024 (65)
  3. 2023 (52)
  4. 2022 (31)
  5. 2021 (6)
  6. 2020 (4)

More Years

Publications
  1. American Journal of Surgical Pathology (28)
  2. Annals of Surgical Oncology (18)
  3. Journal of Gastrointestinal Surgery (15)
  4. Journal of Clinical Oncology (13)
  5. Annals of Surgery (10)
  6. Modern Pathology (10)

More Publications

Publishers
  1. Lippincott Williams & Wilkins (50)
  2. Springer (46)
  3. Elsevier Inc. (20)
  4. Wiley Blackwell (19)
  5. Nature Publishing Group (18)
  6. American Association for Cancer Research (15)

More Publishers

Results (314)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): A randomised, open-label, phase 3 trial
    Journal Article

    Wainberg, Z. A.; Melisi, D.; Macarulla, T.; Pazo Cid, R.; Chandana, S. R.; De La Fouchardière, C.; Dean, A.; Kiss, I.; Lee, W. J.; Goetze, T. O.; more...
    Lancet (2023)

    Fulltext@MSK | Save
  • The unfolded protein response links ER stress to cancer-associated thrombosis
    Journal Article

    Muse, O.; Patell, R.; Peters, C. G.; Yang, M.; El-Darzi, E.; Schulman, S.; Falanga, A.; Marchetti, M.; Russo, L.; Zwicker, J. I.; more...
    JCI Insight (2023)

    Fulltext@MSK | Save
  • Recurring pancreatic neuroendocrine tumor: Timing and pattern of recurrence and current treatment
    Journal Article

    Pulvirenti, A.; Javed, A. A.; Michelakos, T.; Sekigami, Y.; Zheng, J.; Kalvin, H. L.; McIntyre, C. A.; Nebbia, M.; Chou, J. F.; Gonen, M.; more...
    Annals of Surgery (2023)

    Fulltext@MSK | Save
  • Intraductal neoplasms of the pancreatobiliary tract: Navigating the alphabet
    Review

    Xue, Y.; Basturk, O.
    Histopathology (2023)

    Fulltext@MSK | Save
  • Real-time 4D MRI using MR signature matching (MRSIGMA) on a 1.5T MR-Linac system
    Journal Article

    Wu, C.; Murray, V.; Siddiq, S. S.; Tyagi, N.; Reyngold, M.; Crane, C.; Otazo, R.
    Physics in Medicine and Biology (2023)

    Fulltext@MSK | Save
  • Consensus report of the 2021 National Cancer Institute neuroendocrine tumor clinical trials planning meeting
    Editorial

    Singh, S.; Hope, T. A.; Bergsland, E. B.; Bodei, L.; Bushnell, D. L.; Chan, J. A.; Chasen, B. R.; Chauhan, A.; Das, S.; Dasari, A.; more...
    JNCI: Journal of the National Cancer Institute (2023)

    Fulltext@MSK | Save
  • A phase II study of bevacizumab and temsirolimus in advanced extra-pancreatic neuroendocrine tumors
    Journal Article

    Abuzakhm, S. M.; Sukrithan, V.; Fruth, B.; Qin, R.; Strosberg, J.; Hobday, T. J.; Semrad, T.; Reidy-Lagunes, D.; Kindler, H. L.; Kim, G. P.; more...
    Endocrine-Related Cancer (2023)

    Fulltext@MSK | Save
  • KRAS(G12D) inhibition in pancreatic cancer: Fas expression facilitates immune clearance
    Editorial

    Yeh, C.; Park, W.; Yaeger, R.
    Developmental Cell (2023)

    Fulltext@MSK | Save
  • Genetic susceptibility to nonalcoholic fatty liver disease and risk for pancreatic cancer: Mendelian randomization
    Journal Article

    King, S. D.; Veliginti, S.; Brouwers, M. C. G. J.; Ren, Z.; Zheng, W.; Setiawan, V. W.; Wilkens, L. R.; Shu, X. O.; Arslan, A. A.; Beane Freeman, L. E.; more...
    Cancer Epidemiology Biomarkers and Prevention (2023)

    Fulltext@MSK | Save
  • Patient-reported adverse events during neoadjuvant therapy in a phase 2 borderline resectable pancreatic cancer clinical trial (Alliance A021501)
    Conference Paper

    Snyder, R. A.; Dueck, A. C.; Fruth, B.; Shi, Q.; Hubbard, J. M.; Herman, J. M.; O'Reilly, E. M.; Katz, M. H. G.
    Lippincott Williams & Wilkins (2023)

    Fulltext@MSK | Save